Wegovy 2.4 mg

Carrito de la compra

Casa
Checkout
Tienda
0Lista de deseos
  1. Casa
  2. La pérdida de peso
Prev
Dexamphetamine Tentin 5 mg
Dexamphetamine Tentin 5 mgPrecio actual: €80. Precio Original era: €90.
Siguiente
Ozempic 2mg€170
Ozempic 2mg
Wegovy 2.4 mg

Wegovy 2.4 mg

Sold: 0

€180

Wegovy 2,4 mg representa una herramienta poderosa en la lucha contra la obesidadRespaldado por la ciencia y resultados exitosos en la práctica. Si estás listo para controlar tu peso, consulta hoy mismo con un profesional de la salud para determinar si este medicamento es adecuado para ti. Recuerda que un cambio duradero se logra con decisiones informadas y apoyo constante.

Wegovy 2.4 mg

€180

Añadir a la cesta
Comprar Ahora
Categoría: Etiqueta:

Descripción Del Producto

Wegovy 2.4 mg

Wegovy 2.4 mg (semaglutide) is an FDA-approved prescription injectable medication designed for chronic weight management in adults with obesity or overweight conditions accompanied by weight-related medical issues. Representing the maximum therapeutic maintenance dose, Wegovy 2.4 mg is administered once weekly alongside a reduced-calorie meal plan and increased physical activity to support long-term weight loss.

How Wegovy 2.4 mg Works

Wegovy belongs to a class of medications called glucagon-like peptide-1 (GLP-1) receptor agonists. Semaglutide mimics the naturally occurring GLP-1 hormone produced in the intestines, directly targeting areas of the brain that regulate appetite and food intake.

  • Satiety Enhancement: Promotes a feeling of fullness after meals, reducing overall caloric intake and cravings.

  • Retraso del vaciamiento gástrico: Slows the rate at which food leaves the stomach, helping maintain fullness longer.

  • Cardiovascular Benefits: Reduces the risk of major adverse cardiovascular events in adults with established cardiovascular disease and obesity.

Pautas de dosificación y administración

Wegovy 2.4 mg is the final maintenance dose reached after a gradual dose-escalation schedule designed to minimize gastrointestinal side effects.

Parámetro clave Recomendación clínica
Administración Subcutaneous injection into the abdomen, thigh, or upper arm once weekly.
Schedule Administer on the same day each week, at any time of day, with or without food.
Dose Progression Reached after completing 16 weeks of step-up dosing (0.25 mg to 1.7 mg).

Note: Never increase your dosage or alter your administration schedule without explicit medical supervision from your healthcare provider.

Posibles efectos secundarios y advertencias de seguridad

While Wegovy 2.4 mg demonstrates strong clinical efficacy for weight loss, awareness of potential side effects and health precautions is essential.

Los Efectos Secundarios Comunes

  • Náuseas, vómitos y diarrea

  • Constipation, stomach pain, and heartburn

  • Fatigue, headache, and dizziness

  • Mild injection site reactions

Serious Warnings and Precautions

  • Thyroid Tumor Risk: Contraindicado en pacientes con antecedentes personales o familiares de carcinoma medular de tiroides (CMT) o síndrome de neoplasia endocrina múltiple tipo 2 (MEN 2).

  • Pancreatitis aguda: Monitor for persistent, severe abdominal pain that radiates to the back.

  • Riesgo de hipoglucemia: Increased riesgo of low blood sugar when used in combination with insulin secretagogues or insulin.

Top
Top